Latest Phage News

PrecisionPhage will host the Global Phage Therapy Bridge in January 27-28, 2027, in Singapore, a compact gathering designed for the leaders shaping the future of phage therapy.

We are pleased to welcome Pauliina Lajunen, an experienced pharmaceutical and healthcare executive, to our team.

Join us at leading phage and AMR conferences to meet our team and discover Phagenomics BatchQC, launching in 2026.

We have begun systematic, long-term sustainability work.

We are excited to announce our participation in the upcoming AMR Conference 2026 in Basel, Switzerland, one of Europe’s premier gatherings focused on antimicrobial resistance (AMR).

PrecisionPhage joins the BioMedTech incubator, Co11ab Novena, in Singapore. Co11ab Novena is the innovation and translational hub that supports the development of biomedical technologies from research to real-world use.

PrecisionPhage introduces the first accessible and comprehensive, next generation phage bioinformatics software platforms for phage research and GMP-level production. Watch demo videos and read more!

Our team delivers phage services worldwide, drawing on long-term scientific knowledge and expertise. See the phage lab and business environments we work from!

PrecisionPhage is an academically rooted company at the forefront of bacteriophage research and applications. The company's team comprises specialists from Finnish universities and international institutions. Our extensive research portfolio underpins PrecisionPhage's mission to develop high-quality applications for combating antibiotic-resistant infections.